Parker, Megan
Jiang, Kelly
Kalluri, Anita
Arbuiso, Alyssa G.
Carmichael, Austin
Materi, Joshua
Azad, Tej D.
Ha, Jinny Suk
Sahebjam, Solmaz
Kamson, David O.
Redmond, Kristin J.
Kleinberg, Lawrence R.
Ye, Xiaobu
Bettegowda, Chetan
Rincon-Torroella, Jordina
Article History
Received: 28 April 2025
Accepted: 17 June 2025
First Online: 21 July 2025
Declarations
:
: Ethics approval was granted by the Institutional Review Board and Johns Hopkins University. Consent to participate was waived by the Institutional Review Board and Johns Hopkins University.
: Consent to publish was not required for this study.
: C.B.: is a consultant for Depuy-Synthes, Bionaut Labs, Galectin Therapeutics, Haystack Oncology, and Privo Technologies. C.B. is a co-founder of OrisDx and Belay Diagnostics. K.J.R.: Research funding from Accuray, Canon, Elekta AB, icotec; travel expenses from Elekta AB, Accuray, icotec, Brainlab; patent under development with Canon for radiogenomics; data safety monitoring board for BioMimetix.
: This study was presented as a poster presentation at the Congress of Neurological Surgeons 2024 Annual Meeting in Houston, Texas.